Biotech Essentials

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech Essentials

Top news of the week: 20.10.2021.

Biotechnology
Coats
Influenza
PEG ratio
University of California, Berkeley
Massachusetts

Startups

@GENbio shared
On Oct 14, 2021
RT @xiaofei_lin: #Academia tends to have the motto 'stick with the old.' I didn't go into #scicomm to perpetuate norms. I'm here to break barriers with innovation. Launching @GENBiotechJrnl is such an opportunity. My new commentary with @KevinADavies via @GENbio!👉 https://t.co/QgrCiViO8r 1/
Open
Why We’re Launching GEN Biotechnology

Why We’re Launching GEN Biotechnology

In 1981, Genetic Engineering and Biotechnology News launched as the newspaper of record for the fledgling biotechnology industry. Publications come and go, but GEN has stayed the course for ...

@ReutersBiz shared
On Oct 15, 2021
Analysis: Deals, data buzz could help biotech shares exit Wall St's 'no man's land' https://t.co/nEF4MNWUgC https://t.co/vK5AUMRZaF
Open
Analysis: Deals, data buzz could help biotech shares exit Wall St's 'no man's land'

Analysis: Deals, data buzz could help biotech shares exit Wall St's 'no man's land'

Sluggish U.S. biotech shares could require a wave of deal-making or exciting clinical trial results if the sector wants to join the stock market's party after lagging Wall Street's broad ...

@FlagshipPioneer shared
On Oct 15, 2021
Flagship Founder & CEO @NoubarAfeyan shares career shaping experiences and how Flagship and its companies are transforming biotech to improve human health in this @barronsonline Q&A. @blalpert https://t.co/RmsK0xAQ9g @endlessRNA @moderna_tx @OmegaTX @ring_tx @TesseraTx
Open
The Man Behind Moderna on What’s Next in Biotech

The Man Behind Moderna on What’s Next in Biotech

Noubar Afeyan runs a unique venture creation business called Flagship Pioneering, which doesn’t just invest in companies—it develops areas of innovation and performs the research.

@ReutersBiz shared
On Oct 18, 2021
China hopes to work closer with U.S. firms in NEVs, biopharma -industry minister https://t.co/WePyzUFlpk https://t.co/99tRsufc2X
Open
China hopes to work closer with U.S. firms in NEVs, biopharma -industry minister

China hopes to work closer with U.S. firms in NEVs, biopharma -industry minister

China hopes U.S. firms will strengthen their cooperation with Chinese companies in the areas of new energy vehicles, biopharma and next-generation information and communication technology, ...

@big4bio shared
On Oct 19, 2021
Massachusetts and California, the states with the two largest #biopharma clusters, report growing workforces along with business activity. Massachusetts saw its #workforce grow by 5% (4,324 jobs), and California grew by 0.5% (488,665). Learn more here: https://t.co/WNAsXffLmS
Open
Now Hiring: COVID-19, VC Surge Fuels Biotech Job Gains in Massachusetts and California

Now Hiring: COVID-19, VC Surge Fuels Biotech Job Gains in Massachusetts and California

The life sciences workforce grew in 2020 to all-time highs in the states with the nation’s two largest biopharma clusters, according to recently published data by industry groups in ...

@Forbes shared
On Oct 17, 2021
Spoiler: At the top of the list is Harvard. https://t.co/JBB5BF9jgB
Open
More Than One-Fourth Of America’s 400 Richest Went To One Of These 12 Colleges

More Than One-Fourth Of America’s 400 Richest Went To One Of These 12 Colleges

While the nation's wealthiest graduated from more than 150 universities, these schools have the most Forbes 400 alumni.

@BusinessInsider shared
On Oct 15, 2021
Leaked memo: Moderna's CEO responds to criticism of the $135 billion biotech prioritizing vaccine profits over helping poorer countries https://t.co/ER6vhte3Ep
Open
Leaked memo: Moderna's CEO responds to criticism that the $135 billion biotech is prioritizing vaccine profits over helping poorer countries

Leaked memo: Moderna's CEO responds to criticism that the $135 billion biotech is prioritizing vaccine profits over helping poorer countries

"We are now criticized for doing what we promised," Moderna CEO Stéphane Bancel wrote in response to criticism of its COVID-19 vaccine distribution.

@MassBio shared
On Oct 19, 2021
By leveraging the MassBio Edge & @CrownUniform, LabCentral’s intricate organization can focus on research & not the management of lab coat inventories. Read our Edge Partner Spotlight to learn more about this partnership: https://t.co/NODzZYffD0
Open
MassBioEdge Partner Spotlight: LabCentral Experiences the Crown Difference

MassBioEdge Partner Spotlight: LabCentral Experiences the Crown Difference

LabCentral, a shared laboratory space designed as a launchpad for life sciences and biotech startups, partners with Crown through the MassBioEdge, for its full-service lab coat program. ...

Read more: Startups
weekly 20.10.2021
View archives
Back to home

Subscribe to Biotech Essentials - Startups.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech Essentials - Startups.
Privacy Policy

Sign up for the weekly Biotech Essentials - Startups newsletter

Never again miss anything or anyone that matter in Biotech Essentials

Sign up and receive the Biotech Essentials - Startups weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy